Correlation Between Larimar Therapeutics and Incyte
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Incyte, you can compare the effects of market volatilities on Larimar Therapeutics and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Incyte.
Diversification Opportunities for Larimar Therapeutics and Incyte
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Larimar and Incyte is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Incyte go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Incyte
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 2.98 times more return on investment than Incyte. However, Larimar Therapeutics is 2.98 times more volatile than Incyte. It trades about 0.07 of its potential returns per unit of risk. Incyte is currently generating about 0.07 per unit of risk. If you would invest 340.00 in Larimar Therapeutics on August 24, 2024 and sell it today you would earn a total of 273.00 from holding Larimar Therapeutics or generate 80.29% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Incyte
Performance |
| Timeline |
| Larimar Therapeutics |
| Incyte |
Larimar Therapeutics and Incyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Incyte
The main advantage of trading using opposite Larimar Therapeutics and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |